MedElevator Войти в исследования
← Поиск публикаций

DOI 10.7150/ijbs.130351

Медицинская библиотека · International journal of biological sciences · 2026

Hyperglycemia in Diabetes Drives Hepatic Fibrosis Through the Non-Enzymatic Function of HK2 and AGEs-mediated Matrix Stiffening.

Huang Chuxin, Qian Jiali, Zhang Li, Liu Ying, Zhou Qiwen, Li Jiajun, Zhao Yingying, Yu Hongmei, Zhang Yawen, Huang Jinya, Li Miao, Ren Ziyu, Xu Zihao, Liu Rui, Wang Xuanchun, Chen Jie, Cui Jiefeng, Yang Yehong

СтатьяПеревод в очереди

Аннотация

Diabetes is implicated in accelerating the progression of hepatic fibrosis, and empagliflozin (an SGLT2 inhibitor) has potential therapeutic effects on diabetic hepatic fibrosis. However, their underlying mechanisms are still largely uncharacterized. In this study, we found that diabetes obviously promoted hepatic fibrosis progression, and empagliflozin intervention effectively impeded this pathological process independent of its hypoglycemic effects. Mechanistically, high glucose stimulation significantly increased HSC activation and its metabolic enzyme HK2 dissociation from mitochondria. The dissociated HK2 interacted with STAT3 to increase its nuclear entry for upregulating HSC activation-associated gene expression. Meanwhile, high glucose stimulation also suppressed KLF4 expression to attenuate its inhibitory effect on STAT3 transcription activation in HSCs. Additionally, high glucose-induced AGEs accumulation resulted in matrix stiffening, which also increased HSC activation. Empagliflozin alleviated hepatic fibrosis progression through decreasing AGEs accumulation and suppressing STAT3 and FOXO1 phosphorylation in HSCs. From the new perspectives of the non-metabolic functions of metabolic enzymes and matrix biomechanics, this study sheds light on a new synergistic regulatory pathway through which diabetes promotes hepatic fibrosis and highlights empagliflozin as a potential therapeutic agent for diabetic hepatic fibrosis.

Для цитирования: Huang Chuxin, Qian Jiali, Zhang Li, Liu Ying, Zhou Qiwen, Li Jiajun, Zhao Yingying, Yu Hongmei, Zhang Yawen, Huang Jinya, Li Miao, Ren Ziyu, Xu Zihao, Liu Rui, Wang Xuanchun, Chen Jie, Cui Jiefeng, Yang Yehong. Hyperglycemia in Diabetes Drives Hepatic Fibrosis Through the Non-Enzymatic Function of HK2 and AGEs-mediated Matrix Stiffening.. International journal of biological sciences. 2026. DOI: 10.7150/ijbs.130351.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.